Skip to main content
. Author manuscript; available in PMC: 2019 Oct 4.
Published in final edited form as: Curr Probl Surg. 2018 Oct 4;55(9):330–379. doi: 10.1067/j.cpsurg.2018.08.004

Table 2.

Chief complaints, signs, and liver function tests of patients with colorectal cancer liver metastasis who died of disease, by dominant metastatic site.

Liver Dominant (n=231) N %
 LFT abnormality 183 79.2
 Liver failure 24 10.4
Symptoms/Signs
 Jaundice 66 28.6
 Cachectic 40 17.3
 Hepatic encephalopathy 21 9.1
 Abdominal distension 20 8.7
 Hepatomegaly 26 11.3
 Pain 24 10.4
 Infectious disease 13 5.6
 Respiratory distress 18 7.8
 GI bleeding 3 1.3
Intraabdominal Sites Dominant (n=76) N %
 Liver metastases exist 50 65.8
 LFT abnormality 35 46.1
 Liver failure 0 0.0
Symptoms/Signs
 Peritonitis carcinomatosis 20 26.3
 Pain 13 17.1
 Abdominal distension 12 15.8
 Cachectic 16 21.1
 Infectious disease 4 5.3
 Respiratory distress 2 2.6
 GI bleeding 2 2.6
 Vaginal bleeding 2 2.6
 Others 5 6.6
Intrathoracic Sites Dominant (n=53) N %
 Liver metastases exist 27 50.9
 LFT abnormality 11 20.8
 Liver failure 0 0.0
Symptoms/signs
 Respiratory distress 30 56.6
 Cachectic 8 15.1
 Pain 5 9.4
 Infectious disease 4 7.5
 Hemoptysis 1 1.9
 Others 4 7.5
Bone Dominant (n=30) N %
 Liver metastases exist 18 60.0
 LFT abnormality 12 40.0
 Liver failure 0 0.0
Symptoms/Signs
 Pain 20 66.7
 Spinal cord compression 8 26.7
 Cachectic 1 3.3
 Respiratory distress 1 3.3
Brain Dominant (n=34) N %
 Liver metastases exist 24 70.6
 LFT abnormality 15 44.1
 Liver failure 0 0.0
Symptoms/Signs
 Focal neurologic symptoms 20 58.8
 Altered mental status 3 8.8
 Pain 3 8.8
 Respiratory distress 2 5.9
 Headache 2 5.9
 Cachectic 2 5.9
 Others 2 5.9

Notes: GI, gastrointestinal; LFT, liver function test